TMC
TNDM icon

Trellus Management Company’s Tandem Diabetes Care TNDM Stock Holding History

Trellus Management Company’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-10,000
Closed -$592K – 69
2022
Q2 		$592K Buy
+10,000
New +$821K 0.72% 25
2019
Q3 		– Sell
-4,542
Closed -$293K – 83
2019
Q2 		$293K Buy
+4,542
New +$293K 0.4% 54

Other funds holding TNDM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Trellus Management Company's TNDM Position: Q3 2022 in Review

Trellus Management Company sold out of Tandem Diabetes Care (TNDM) in Q3 2022, closing a stake of 10,000 shares — an estimated $592K sold.

Trellus Management Company first reported a position in TNDM in Q2 2019 and held it in 2 quarters. The position peaked at $592K in Q2 2022. 299 funds tracked by Wall St. Rank hold TNDM as of Q3 2022.

  • Trellus Management Company reported no remaining Tandem Diabetes Care position as of Q3 2022 after selling out during the quarter.
  • Trellus Management Company sold 10,000 Tandem Diabetes Care shares in Q3 2022, an estimated $592K.
  • Trellus Management Company first reported a position in Tandem Diabetes Care in Q2 2019 and held it in 2 quarters.
  • Trellus Management Company's Tandem Diabetes Care position peaked at $592K in Q2 2022.
  • 299 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2022.

Based on Trellus Management Company's 13F filing for Q3 2022, filed 25 Oct 2022.